Skip to content

An ecological momentary compassion-focused intervention for enhancing resilience in help-seeking youths

An ecological momentary compassion-focused intervention for enhancing resilience in help-seeking youths - EMOCOMPASS

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON45680
Enrollment
150
Registered
2017-10-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

angst en depressieve symptomen psychotic symptoms psychotic-like experiences

Interventions

Participants in the experimental condition will receive the ecological momentary, compassion-focused intervention (EMOCOMPASS),which will consist of three face-to-face sessions (1 training session,

Sponsors

Mondriaan Zorggroep (Heerlen)
Lead Sponsor

Eligibility

Age
12 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Age from 15 until 26 years 2. Score of 6 or above on the PQ, a T-score of 63 or above on the BSI, and/or a score above the cutoff on the SQ-48 (i.e., on the social phobia (>9), depression (>8), or anxiety (>11) subscale) 3. Willingness to participate in the compassion-focused ecological momentary intervention 4. Ability to give written informed consent independently

Exclusion criteria

Exclusion criteria: 1. Insufficient command of Dutch so that the compassioned-focused ecological momentary intervention cannot be followed and outcomes cannot be reasonably assessed in Dutch 2. Clinical diagnosis of alcohol or substance dependency, severe endocrine, cardiovascular or organic brain disease

Design outcomes

Primary

MeasureTime frame
Stress sensitivity, psychotic, anxiety and depressive symptoms measured with Ecological Momentary Assessment (EMA) and other validated measures will be the primary outcomes, which will be obtained before randomization (*baseline*), at the end of the 3-week intervention period (*post-intervention*), and after a 4-week and 10-week follow-up period (*follow-up*). Our primary hypothesis relates to endpoints at the end of treatment.

Secondary

MeasureTime frame
The secondary study parameters will be threat anticipation, appraisal of emotions, interpersonal sensitivity, and general psychopathology, measured with EMA and other validated measures. As the primary outcomes, secondary outcomes will be obtained before randomization (*baseline*), at the end of the 3-week intervention period (*post-intervention*), and after a 4-week and 10 week follow-up period (*follow-up*).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)